These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9608885)

  • 1. Uptake of ethylenediamine tetramethylene phosphonic acid in normal bone after multiple applications. A non-human primate study.
    Dormehl IC; Louw WK; Schneeweiss FH; Milner R; Schmitt G; Carl U; Croft SA
    Arzneimittelforschung; 1998 Apr; 48(4):408-14. PubMed ID: 9608885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of samarium-153 and holmium-166-EDTMP in the normal baboon model.
    Louw WK; Dormehl IC; van Rensburg AJ; Hugo N; Alberts AS; Forsyth OE; Beverley G; Sweetlove MA; Marais J; Lötter MG; van Aswegen A
    Nucl Med Biol; 1996 Nov; 23(8):935-40. PubMed ID: 9004281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer.
    Singh A; Holmes RA; Farhangi M; Volkert WA; Williams A; Stringham LM; Ketring AR
    J Nucl Med; 1989 Nov; 30(11):1814-8. PubMed ID: 2478681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethylene diamine tetramethylene phosphonic acid labeled with various β(-)-emitting radiometals: labeling optimization and animal biodistribution.
    Sohaib M; Ahmad M; Jehangir M; Perveen A
    Cancer Biother Radiopharm; 2011 Apr; 26(2):159-64. PubMed ID: 21510750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Samarium 153Sm lexidronam.
    Lamb HM; Faulds D
    Drugs Aging; 1997 Nov; 11(5):413-8; discussion 419. PubMed ID: 9359026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated human absorbed dose of a new (153)Sm bone seeking agent based on biodistribution data in mice: Comparison with (153)Sm-EDTMP.
    Yousefnia H; Zolghadri S
    Phys Med; 2015 Nov; 31(7):714-9. PubMed ID: 26095757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Samarium-153 EDTMP therapy of disseminated skeletal metastasis.
    Turner JH; Martindale AA; Sorby P; Hetherington EL; Fleay RF; Hoffman RF; Claringbold PG
    Eur J Nucl Med; 1989; 15(12):784-95. PubMed ID: 2483138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent.
    Máthé D; Balogh L; Polyák A; Király R; Márián T; Pawlak D; Zaknun JJ; Pillai MR; Jánoki GA
    Nucl Med Biol; 2010 Feb; 37(2):215-26. PubMed ID: 20152721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying the radiation dosage to individual skeletal lesions treated with samarium-153-EDTMP.
    van Rensburg AJ; Alberts AS; Louw WK
    J Nucl Med; 1998 Dec; 39(12):2110-5. PubMed ID: 9867152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Samarium-153-EDTMP bone uptake rate and its relation to therapeutic effect.
    Li L; Liang Z; Deng H; Kuang A; Tan T; Luo S
    Chin Med J (Engl); 2002 Jul; 115(7):1096-8. PubMed ID: 12173602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a freeze-dried kit for EDTMP-based bone-seeking radiopharmaceuticals.
    Garnuszek P; Pawlak D; Licińska I; Kamińska A
    Appl Radiat Isot; 2003 Apr; 58(4):481-8. PubMed ID: 12672628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (170)Tm-EDTMP: a potential cost-effective alternative to (89)SrCl(2) for bone pain palliation.
    Das T; Chakraborty S; Sarma HD; Tandon P; Banerjee S; Venkatesh M; Pillai MR
    Nucl Med Biol; 2009 Jul; 36(5):561-8. PubMed ID: 19520297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Samarium for osteoblastic bone metastases and osteosarcoma.
    Anderson P
    Expert Opin Pharmacother; 2006 Aug; 7(11):1475-86. PubMed ID: 16859431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases.
    Thapa P; Nikam D; Das T; Sonawane G; Agarwal JP; Basu S
    J Nucl Med; 2015 Oct; 56(10):1513-9. PubMed ID: 26315829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous study of the biodistribution of radio-yttrium complexed with EDTMP and citrate ligands in tumour-bearing rats.
    Beyer GJ; Bergmann R; Kampf G; Mäding P; Rösch F
    Int J Rad Appl Instrum B; 1992 Feb; 19(2):201-3. PubMed ID: 1601673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [153Sm-EDTMP for moderate and severe bone cancer pain].
    Deng H; Luo S; Tan T; Mo T; Liang Z; Pu M; Jiao J; Zhong S; Wang Q; Hu Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):391-4. PubMed ID: 8732058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biospeciation, by potentiometry and computer simulation, of Sm-EDTMP, a bone tumor palliative agent.
    Charmaine de Witt G; May PM; Webb J; Hefter G
    Biometals; 1996 Oct; 9(4):351-61. PubMed ID: 8837456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical.
    Simón J; Frank RK; Crump DK; Erwin WD; Ueno NT; Wendt RE
    Nucl Med Biol; 2012 Aug; 39(6):770-6. PubMed ID: 22459336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis.
    Serafini AN
    Q J Nucl Med; 2001 Mar; 45(1):91-9. PubMed ID: 11456381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer.
    Farhanghi M; Holmes RA; Volkert WA; Logan KW; Singh A
    J Nucl Med; 1992 Aug; 33(8):1451-8. PubMed ID: 1378887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.